Omega Diagnostics Group Plc (ODX):企業の財務・戦略的SWOT分析

◆英語タイトル:Omega Diagnostics Group Plc (ODX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14840
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company provides products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests for diseases such as renal disease, connective tissue disease and anaemia. Omega offers diagnosis of infectious diseases, including Syphilis, TB and Dengue Fever. The company supplies tests based on agglutination, enzyme immunoassay, fluorescence, rapid and micro-array technologies. It markets its diagnostic kits and systems to hospitals, blood banks, clinics and laboratories. The company operates in the UK, Germany and India. Omega is headquartered in Alva, the UK.

Omega Diagnostics Group Plc Key Recent Developments

Mar 01,2019: Omega diagnostics Group: Board appointment
Dec 10,2018: Omega Diagnostics Group: Directorate Change
Dec 03,2018: Omega Diagnostics Group: Interim results for the six months ended 30 September 2018
Sep 27,2018: Omega Diagnostics Group: Allergy CE-Mark and first Purchase Order
Aug 06,2018: Omega Diagnostics: Visitect CD4 advanced disease development update

This comprehensive SWOT profile of Omega Diagnostics Group Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Omega Diagnostics Group Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Omega Diagnostics Group Plc – Key Information
Omega Diagnostics Group Plc – Overview
Omega Diagnostics Group Plc – Key Employees
Omega Diagnostics Group Plc – Key Employee Biographies
Omega Diagnostics Group Plc – Key Operational Heads
Omega Diagnostics Group Plc – Major Products and Services
Omega Diagnostics Group Plc – History
Omega Diagnostics Group Plc – Company Statement
Omega Diagnostics Group Plc – Locations And Subsidiaries
Omega Diagnostics Group Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Omega Diagnostics Group Plc – Business Description
Omega Diagnostics Group Plc – Corporate Strategy
Omega Diagnostics Group Plc – SWOT Analysis
SWOT Analysis – Overview
Omega Diagnostics Group Plc – Strengths
Omega Diagnostics Group Plc – Weaknesses
Omega Diagnostics Group Plc – Opportunities
Omega Diagnostics Group Plc – Threats
Omega Diagnostics Group Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Omega Diagnostics Group Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Omega Diagnostics Group Plc, Key Information
Omega Diagnostics Group Plc, Key Ratios
Omega Diagnostics Group Plc, Share Data
Omega Diagnostics Group Plc, Major Products and Services
Omega Diagnostics Group Plc, History
Omega Diagnostics Group Plc, Key Employees
Omega Diagnostics Group Plc, Key Employee Biographies
Omega Diagnostics Group Plc, Key Operational Heads
Omega Diagnostics Group Plc, Other Locations
Omega Diagnostics Group Plc, Subsidiaries
Omega Diagnostics Group Plc, Key Manufacturing facilities
Omega Diagnostics Group Plc, Key Competitors
Omega Diagnostics Group Plc, SWOT Analysis
Omega Diagnostics Group Plc, Ratios based on current share price
Omega Diagnostics Group Plc, Annual Ratios
Omega Diagnostics Group Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Omega Diagnostics Group Plc, Performance Chart
Omega Diagnostics Group Plc, Ratio Charts

★海外企業調査レポート[Omega Diagnostics Group Plc (ODX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Keysight Technologies Inc:戦略・SWOT・企業財務分析
    Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Valneva SE (VLA):企業の財務・戦略的SWOT分析
    Valneva SE (VLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Maxim Integrated Products, Inc.:企業の戦略・SWOT・財務分析
    Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Mizuho Financial Group Inc:企業のM&A・事業提携・投資動向
    Mizuho Financial Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mizuho Financial Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • First Ship Lease Trust (D8DU):企業の財務・戦略的SWOT分析
    First Ship Lease Trust (D8DU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Wien Energie GmbH:企業の戦略的SWOT分析
    Wien Energie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Tocagen Inc (TOCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Tocagen Inc (Tocagen) is a clinical-stage cancer-selective gene therapy company that develops and commercializes product candidates for the treatment of cancer. The company offers lead product candidate such as Toca 511 and Toca FC, which is being investigated for the treatment of recurrent …
  • MediWound Ltd (MDWD):医療機器:M&Aディール及び事業提携情報
    Summary MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’ …
  • Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • FANUC CORPORATION:企業の戦略・SWOT・財務分析
    FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report Summary FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • FMR LLC:企業の戦略的SWOT分析
    FMR LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Laval University:製薬・医療:M&Aディール及び事業提携情報
    Summary Laval University is an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate, degree programs and distance education programs. It offers courses in the fields of advanced international studies, agriculture and food scien …
  • Hollister Inc:企業の戦略的SWOT分析
    Hollister Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Guangshen Railway Company Limited:企業の戦略・SWOT・財務情報
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Patheon NV:戦略・SWOT・企業財務分析
    Patheon NV - Strategy, SWOT and Corporate Finance Report Summary Patheon NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Seaboard Corporation:企業の戦略・SWOT・財務情報
    Seaboard Corporation - Strategy, SWOT and Corporate Finance Report Summary Seaboard Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Myriad Genetics Inc (MYGN):企業の製品パイプライン分析2018
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …
  • Iluka Resources Ltd:企業の戦略・SWOT・財務情報
    Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • Neurocrine Biosciences Inc (NBIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆